Aneurysm Syndromes Caused by Mutations in the TGF- Receptor
Bart L. Loeys, M.D., Ph.D., Ulrike Schwarze, M.D., Tammy Holm, M.D., Bert L. Callewaert, M.D., George H. Thomas, Ph.D., Hariyadarshi Pannu, Ph.D., Julie F. De Backer, M.D., Gretchen L. Oswald, M.S., Sofie Symoens, B.S., Sylvie Manouvrier, M.D., Ph.D., Amy E. Roberts, M.D., Francesca Faravelli, M.D., M. Alba Greco, M.D., Reed E. Pyeritz, M.D., Ph.D., Dianna M. Milewicz, M.D., Ph.D., Paul J. Coucke, Ph.D., Duke E. Cameron, M.D., Alan C. Braverman, M.D., Peter H. Byers, M.D., Anne M. De Paepe, M.D., Ph.D., and Harry C. Dietz, M.D.
Background The LoeysDietz syndrome is a recently describedautosomal dominant aortic-aneurysm syndrome with widespreadsystemic involvement. The disease is characterized by the triadof arterial tortuosity and aneurysms, hypertelorism, and bifiduvula or cleft palate and is caused by heterozygous mutationsin the genes encoding transforming growth factor receptors1 and 2 (TGFBR1 and TGFBR2, respectively).
Methods We undertook the clinical and molecular characterizationof 52 affected families. Forty probands presented with typicalmanifestations of the LoeysDietz syndrome. In view ofthe phenotypic overlap between this syndrome and vascular EhlersDanlossyndrome, we screened an additional cohort of 40 patients whohad vascular EhlersDanlos syndrome without the characteristictype III collagen abnormalities or the craniofacial featuresof the LoeysDietz syndrome.
Results We found a mutation in TGFBR1 or TGFBR2 in all probandswith typical LoeysDietz syndrome (type I) and in 12 probandspresenting with vascular EhlersDanlos syndrome (LoeysDietzsyndrome type II). The natural history of both types was characterizedby aggressive arterial aneurysms (mean age at death, 26.0 years)and a high incidence of pregnancy-related complications (in6 of 12 women). Patients with LoeysDietz syndrome typeI, as compared with those with type II, underwent cardiovascularsurgery earlier (mean age, 16.9 years vs. 26.9 years) and diedearlier (22.6 years vs. 31.8 years). There were 59 vascularsurgeries in the cohort, with one death during the procedure.This low rate of intraoperative mortality distinguishes theLoeysDietz syndrome from vascular EhlersDanlossyndrome.
Conclusions Mutations in either TGFBR1 or TGFBR2 predisposepatients to aggressive and widespread vascular disease. Theseverity of the clinical presentation is predictive of the outcome.Genotyping of patients presenting with symptoms like those ofvascular EhlersDanlos syndrome may be used to guide therapy,including the use and timing of prophylactic vascular surgery.
Source Information
From the McKusickNathans Institute for Genetic Medicine (B.L.L., T.H., G.H.T., G.L.O., H.C.D.) and the Department of Surgery (D.E.C.), Johns Hopkins University School of Medicine, and the Kennedy Krieger Institute (G.H.T.) both in Baltimore; the Departments of Pathology and Medicine, University of Washington, Seattle (U.S., P.H.B.); the Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium (B.L.L., B.L.C., J.F.D.B., S.S., P.J.C., A.M.D.P.); the Department of Medicine, University of Texas, Houston (H.P., D.M.M.); the Department of Clinical Genetics, University Hospital, Lille, France (S.M.); the Department of Clinical Genetics, Harvard Medical School, Boston (A.E.R.); the Department of Human Genetics, Ospedale Galliera, Genoa, Italy (F.F.); the Department of Pathology, New York University School of Medicine, New York (M.A.G.); the Department of Medicine, University of Pennsylvania, Philadelphia (R.E.P.); the Department of Medicine, Washington University School of Medicine, St. Louis (A.C.B.); and Howard Hughes Medical Institute, Chevy Chase, Md. (H.C.D.).
Address reprint requests to Dr. Loeys at the Center for Medical Genetics, Ghent University Hospital, Bldg. 0K5, De Pintelaan 185, 9000 Ghent, Belgium, or at bart.loeys{at}ugent.be.
Schweitzer, M., Mitmaker, B., Obrand, D., Sheiner, N., Abraham, C., Dostanic, S., Meilleur, M., Sugahara, T., Chalifour, L. E.
(2010). Atorvastatin Modulates Matrix Metalloproteinase Expression, Activity, and Signaling in Abdominal Aortic Aneurysms. VASC ENDOVASCULAR SURG
44: 116-122
[Abstract]
Attias, D., Stheneur, C., Roy, C., Collod-Beroud, G., Detaint, D., Faivre, L., Delrue, M.-A., Cohen, L., Francannet, C., Beroud, C., Claustres, M., Iserin, F., Khau Van Kien, P., Lacombe, D., Le Merrer, M., Lyonnet, S., Odent, S., Plauchu, H., Rio, M., Rossi, A., Sidi, D., Steg, P. G., Ravaud, P., Boileau, C., Jondeau, G.
(2009). Comparison of Clinical Presentations and Outcomes Between Patients With TGFBR2 and FBN1 Mutations in Marfan Syndrome and Related Disorders. Circulation
120: 2541-2549
[Abstract][Full Text]
Song, H. K., Bavaria, J. E., Kindem, M. W., Holmes, K. W., Milewicz, D. M., Maslen, C. L., Pyeritz, R. E., Basson, C. T., Eagle, K., Tolunay, H. E., Kroner, B. L., Dietz, H., Menashe, V., Devereux, R. B., Desvigne-Nickens, P., Ravekes, W., Weinsaft, J. W., Brambilla, D., Stylianou, M. P., Hendershot, T., Mitchell, M. S., LeMaire, S. A., National Registry of Genetically Triggered Thoraci,
(2009). Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions.. Ann. Thorac. Surg.
88: 781-787
[Abstract][Full Text]
Shirley, L. E. D., Sponseller, P. D.
(2009). Marfan Syndrome. J Am Acad Orthop Surg
17: 572-581
[Abstract][Full Text]
Lundby, R., Rand-Hendriksen, S., Hald, J.K., Lilleas, F.G., Pripp, A.H., Skaar, S., Paus, B., Geiran, O., Smith, H.-J.
(2009). Dural Ectasia in Marfan Syndrome: A Case Control Study. Am. J. Neuroradiol.
30: 1534-1540
[Abstract][Full Text]
Rodrigues, V.J., Elsayed, S., Loeys, B.L., Dietz, H.C., Yousem, D.M.
(2009). Neuroradiologic Manifestations of Loeys-Dietz Syndrome Type 1. Am. J. Neuroradiol.
30: 1614-1619
[Abstract][Full Text]
Tran-Fadulu, V, Pannu, H, Kim, D H, Vick, G W III, Lonsford, C M, Lafont, A L, Boccalandro, C, Smart, S, Peterson, K L, Hain, J Z., Willing, M C, Coselli, J S, LeMaire, S A, Ahn, C, Byers, P H, Milewicz, D M
(2009). Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J. Med. Genet.
46: 607-613
[Abstract][Full Text]
Rankin, J. S., Braverman, A. C., Kouchoukos, N. T.
(2009). Total Aortic Replacement in Loeys-Dietz Syndrome.. Ann. Thorac. Surg.
87: 1949-1951
[Abstract][Full Text]
Everitt, M. D., Pinto, N., Hawkins, J. A., Mitchell, M. B., Kouretas, P. C., Yetman, A. T.
(2009). Cardiovascular surgery in children with Marfan syndrome or Loeys-Dietz syndrome.. J. Thorac. Cardiovasc. Surg.
137: 1327-1333
[Abstract][Full Text]
Debette, S., Markus, H. S.
(2009). The Genetics of Cervical Artery Dissection: A Systematic Review. Stroke
40: e459-e466
[Abstract][Full Text]
Desmet, F.-O., Hamroun, D., Lalande, M., Collod-Beroud, G., Claustres, M., Beroud, C.
(2009). Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res
37: e67-e67
[Abstract][Full Text]
Ramanath, V. S., Oh, J. K., Sundt, T. M. III, Eagle, K. A.
(2009). Acute Aortic Syndromes and Thoracic Aortic Aneurysm. Mayo Clin Proc.
84: 465-481
[Abstract][Full Text]
Santiago-Sim, T., Mathew-Joseph, S., Pannu, H., Milewicz, D. M., Seidman, C. E., Seidman, J.G., Kim, D. H.
(2009). Sequencing of TGF-{beta} Pathway Genes in Familial Cases of Intracranial Aneurysm. Stroke
40: 1604-1611
[Abstract][Full Text]
Lin, P. H., Huynh, T. T., Kougias, P., Huh, J., LeMaire, S. A., Coselli, J. S.
(2009). Descending Thoracic Aortic Dissection: Evaluation and Management in the Era of Endovascular Technology. VASC ENDOVASCULAR SURG
43: 5-24
[Abstract]
Pyeritz, R. E
(2009). Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart
95: 173-175
[Full Text]
Cheng, C.-H., Kikuchi, T., Chen, Y.-H., Sabbagha, N. G. A.-A.-A., Lee, Y.-C., Pan, H.-J., Chang, C., Chen, Y.-T.
(2009). Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc Res
81: 381-388
[Abstract][Full Text]
Faivre, L., Masurel-Paulet, A., Collod-Beroud, G., Callewaert, B. L., Child, A. H., Stheneur, C., Binquet, C., Gautier, E., Chevallier, B., Huet, F., Loeys, B. L., Arbustini, E., Mayer, K., Arslan-Kirchner, M., Kiotsekoglou, A., Comeglio, P., Grasso, M., Halliday, D. J., Beroud, C., Bonithon-Kopp, C., Claustres, M., Robinson, P. N., Ades, L., De Backer, J., Coucke, P., Francke, U., De Paepe, A., Boileau, C., Jondeau, G.
(2009). Clinical and Molecular Study of 320 Children With Marfan Syndrome and Related Type I Fibrillinopathies in a Series of 1009 Probands With Pathogenic FBN1 Mutations. Pediatrics
123: 391-398
[Abstract][Full Text]
Ahimastos, A. A., Dart, A. M., Kingwell, B. A., Jimenez, S. A., Rosenbloom, J., van Dijk, F. S., Meijers-Heijboer, H., Pals, G., Brooke, B. S., Dietz, H. C. III
(2008). Angiotensin II Blockade in Marfan's Syndrome. NEJM
359: 1732-1734
[Full Text]
He, R., Guo, D.-C., Sun, W., Papke, C. L., Duraisamy, S., Estrera, A. L., Safi, H. J., Ahn, C., Maximilian Buja, L., Arnett, F. C., Zhang, J., Geng, Y.-J., Milewicz, D. M.
(2008). Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms.. J. Thorac. Cardiovasc. Surg.
136: 922-929
[Abstract][Full Text]
Pearson, G. D., Devereux, R., Loeys, B., Maslen, C., Milewicz, D., Pyeritz, R., Ramirez, F., Rifkin, D., Sakai, L., Svensson, L., Wessels, A., Van Eyk, J., Dietz, H. C.
(2008). Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders. Circulation
118: 785-791
[Full Text]
Faivre, L, Collod-Beroud, G, Child, A, Callewaert, B, Loeys, B L, Binquet, C, Gautier, E, Arbustini, E, Mayer, K, Arslan-Kirchner, M, Stheneur, C, Kiotsekoglou, A, Comeglio, P, Marziliano, N, Halliday, D, Beroud, C, Bonithon-Kopp, C, Claustres, M, Plauchu, H, Robinson, P N, Ades, L, De Backer, J, Coucke, P, Francke, U, De Paepe, A, Boileau, C, Jondeau, G
(2008). Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J. Med. Genet.
45: 384-390
[Abstract][Full Text]
Lopez, L., Arheart, K. L., Colan, S. D., Stein, N. S., Lopez-Mitnik, G., Lin, A. E., Reller, M. D., Ventura, R., Silberbach, M.
(2008). Turner Syndrome Is an Independent Risk Factor for Aortic Dilation in the Young. Pediatrics
121: e1622-e1627
[Abstract][Full Text]
Keane, M. G., Pyeritz, R. E.
(2008). Medical Management of Marfan Syndrome. Circulation
117: 2802-2813
[Full Text]
Melenovsky, V., Adamira, M., Kautznerova, D., Voska, L., Weichet, J., Loeys, B., Pirk, J.
(2008). Aortic dissection in a young man with Loeys-Dietz syndrome.. J. Thorac. Cardiovasc. Surg.
135: 1174-1175.e1
[Full Text]
Zaiman, A. L., Podowski, M., Medicherla, S., Gordy, K., Xu, F., Zhen, L., Shimoda, L. A., Neptune, E., Higgins, L., Murphy, A., Chakravarty, S., Protter, A., Sehgal, P. B., Champion, H. C., Tuder, R. M.
(2008). Role of the TGF-{beta}/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary Hypertension. Am. J. Respir. Crit. Care Med.
177: 896-905
[Abstract][Full Text]
Newman, J. H., Phillips, J. A. III, Loyd, J. E.
(2008). Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies. ANN INTERN MED
148: 278-283
[Abstract][Full Text]
Sareli, A. E., Janssen, W. J., Sterman, D., Saint, S., Pyeritz, R. E.
(2008). What's the Connection? -- A 26-year-old white man presented to our referral hospital with a 1-month history of persistent cough productive of white sputum, which was occasionally tinged with blood. NEJM
358: 626-632
[Full Text]
Cheli, Y., Jensen, D., Marchese, P., Habart, D., Wiltshire, T., Cooke, M., Fernandez, J. A., Ware, J., Ruggeri, Z. M., Kunicki, T. J.
(2008). The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice. Blood
111: 1266-1273
[Abstract][Full Text]
Kuivaniemi, H., Platsoucas, C. D., Tilson, M. D. III
(2008). Aortic Aneurysms: An Immune Disease With a Strong Genetic Component. Circulation
117: 242-252
[Full Text]
Matura, L. A., Ho, V. B., Rosing, D. R., Bondy, C. A.
(2007). Aortic Dilatation and Dissection in Turner Syndrome. Circulation
116: 1663-1670
[Abstract][Full Text]
McKellar, S. H., Tester, D. J., Yagubyan, M., Majumdar, R., Ackerman, M. J., Sundt, T. M. III
(2007). Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg.
134: 290-296
[Abstract][Full Text]
Lee, R. S., Fazel, S., Schwarze, U., Fleischmann, D., Berry, G. J., Liang, D., Miller, D. C., Mitchell, R. S.
(2007). Rapid aneurysmal degeneration of a Stanford type B aortic dissection in a patient with Loeys-Dietz syndrome. J. Thorac. Cardiovasc. Surg.
134: 242-243
[Full Text]
Johnson, P. T., Chen, J. K., Loeys, B. L., Dietz, H. C., Fishman, E. K.
(2007). Loeys-Dietz Syndrome: MDCT Angiography Findings. Am. J. Roentgenol.
189: W29-W35
[Abstract][Full Text]
Waldmuller, S., Muller, M., Warnecke, H., Rees, W., Schols, W., Walterbusch, G., Ennker, J., Scheffold, T.
(2007). Genetic testing in patients with aortic aneurysms/dissections: a novel genotype/phenotype correlation?. Eur. J. Cardiothorac. Surg.
31: 970-975
[Abstract][Full Text]
Drera, B., Barlati, S., Colombi, M., Cartwright, M. S., Roach, E. S.
(2007). ISCHEMIC STROKE IN AN ADOLESCENT WITH ARTERIAL TORTUOSITY SYNDROME. Neurology
68: 1637-1637
[Full Text]
Yetman, A. T., Beroukhim, R. S., Ivy, D. D., Manchester, D.
(2007). Importance of the Clinical Recognition of Loeys-Dietz Syndrome in the Neonatal Period. Pediatrics
119: e1199-e1202
[Abstract][Full Text]
Ruiz-Ortega, M., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G., Egido, J.
(2007). TGF-{beta} signaling in vascular fibrosis. Cardiovasc Res
74: 196-206
[Abstract][Full Text]
Grainger, D. J.
(2007). TGF-{beta} and atherosclerosis in man. Cardiovasc Res
74: 213-222
[Abstract][Full Text]
Graham Stuart, A., Williams, A.
(2007). Marfan's syndrome and the heart. Arch. Dis. Child.
92: 351-356
[Abstract][Full Text]
Weiss, R. M.
(2007). Lasting Effects of Lost Vascular Elasticity. Circ. Res.
100: 604-606
[Full Text]
Liang, X., Sun, Y., Schneider, J., Ding, J.-H., Cheng, H., Ye, M., Bhattacharya, S., Rearden, A., Evans, S., Chen, J.
(2007). Pinch1 Is Required for Normal Development of Cranial and Cardiac Neural Crest-Derived Structures. Circ. Res.
100: 527-535
[Abstract][Full Text]
Hoffman, J. D., Estrella, E. A.
(2007). Newborn Presentation of Connective Tissue Disorders. NeoReviews
8: e110-e119
[Abstract][Full Text]
Williams, J. A., Loeys, B. L., Nwakanma, L. U., Dietz, H. C., Spevak, P. J., Patel, N. D., Francois, K., DeBacker, J., Gott, V. L., Vricella, L. A., Cameron, D. E.
(2007). Early Surgical Experience With Loeys-Dietz: A New Syndrome of Aggressive Thoracic Aortic Aneurysm Disease. Ann. Thorac. Surg.
83: S757-S763
[Abstract][Full Text]
Chaudhry, S. S., Cain, S. A., Morgan, A., Dallas, S. L., Shuttleworth, C. A., Kielty, C. M.
(2007). Fibrillin-1 regulates the bioavailability of TGF{beta}1. JCB
176: 355-367
[Abstract][Full Text]
Charitakis, K., Basson, C. T.
(2007). Degenerating Heart Valves: Fill Them up With Filamin?. Circulation
115: 2-4
[Full Text]
Malik, I.
(2006). JournalScan. Heart
92: 1886-1888
[Full Text]
Arbustini, E., Marziliano, N., Magrassi, L., Loeys, B. L., Dietz, H. C.
(2006). Aneurysm Syndromes and TGF-{beta} Receptor Mutations. NEJM
355: 2155-2156
[Full Text]
Oderich, G. S.
(2006). Current Concepts in the Diagnosis and Management of Vascular Ehlers-Danlos Syndrome. PERSPECT VASC SURG ENDOVASC THER
18: 206-214
Ellison, J.
(2006). Commentary on "Current Concepts in the Diagnosis and Management of Vascular Ehlers-Danlos Syndrome". PERSPECT VASC SURG ENDOVASC THER
18: 215-216
Gelb, B. D.
(2006). Marfan's Syndrome and Related Disorders -- More Tightly Connected Than We Thought. NEJM
355: 841-844
[Full Text]